BB&T SECURITIES, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 954 filers reported holding BAXTER INTL INC in Q1 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
BB&T SECURITIES, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2019$3,083,000
-16.5%
35,296
-21.7%
0.03%
-17.6%
Q2 2019$3,692,000
-5.0%
45,084
-5.7%
0.03%
-8.1%
Q1 2019$3,887,000
-2.3%
47,821
-20.9%
0.04%
-15.9%
Q4 2018$3,979,000
-16.4%
60,459
-2.0%
0.04%
-6.4%
Q3 2018$4,757,000
+1.8%
61,714
-2.5%
0.05%
-6.0%
Q2 2018$4,671,000
+16.5%
63,273
+2.6%
0.05%
+11.1%
Q1 2018$4,010,000
+4.8%
61,664
+4.1%
0.04%
-10.0%
Q4 2017$3,827,000
-64.6%
59,212
-65.7%
0.05%
-66.0%
Q3 2017$10,824,000
-0.5%
172,500
-4.0%
0.15%
-7.0%
Q2 2017$10,873,000
-25.8%
179,621
-36.4%
0.16%
-21.0%
Q1 2017$14,649,000
-23.6%
282,484
-32.8%
0.20%
-28.3%
Q4 2016$19,179,000
-4.6%
420,303
-0.5%
0.28%
-6.7%
Q3 2016$20,106,000
+14.8%
422,402
+9.1%
0.30%
+10.3%
Q2 2016$17,508,000
+11.1%
387,175
+0.9%
0.27%
+5.0%
Q1 2016$15,759,000
+94.9%
383,629
+81.0%
0.26%
+52.7%
Q4 2015$8,086,000
+76.5%
211,964
+51.9%
0.17%
+67.3%
Q3 2015$4,582,000
-23.8%
139,498
+62.2%
0.10%
-21.1%
Q2 2015$6,013,000
-98.5%
85,988
-85.6%
0.13%
-85.7%
Q1 2015$409,304,000
-27.1%
597,525
-22.0%
0.90%
-29.0%
Q4 2014$561,397,000
+2.2%
765,995
+0.1%
1.26%
-1.7%
Q3 2014$549,346,000
-1.0%
765,426
-0.3%
1.29%
-2.6%
Q2 2014$554,798,000
-6.7%
767,356
-5.0%
1.32%
-14.2%
Q1 2014$594,552,000
+6.9%
808,036
+1.0%
1.54%
+0.3%
Q4 2013$556,163,000
+24.7%
799,660
+17.7%
1.54%
+11.1%
Q3 2013$446,149,000
-3.1%
679,175
+2.2%
1.38%
-8.2%
Q2 2013$460,449,000664,7171.50%
Other shareholders
BAXTER INTL INC shareholders Q1 2014
NameSharesValueWeighting ↓
Tavio Capital LLC 68,405$5,890,0007.81%
Iron Triangle Partners LP 330,000$28,413,0007.16%
Veritas Asset Management LLP 8,942,428$769,943,0005.64%
TSFG, LLC 93,405$8,042,0005.31%
GENERATION INVESTMENT MANAGEMENT LLP 10,606,094$913,185,0005.27%
Third Point 4,000,000$344,400,0004.72%
Avidity Partners Management LP 800,900$68,957,0004.42%
Palmer Knight Co 62,275$5,362,0004.17%
Eos Focused Equity Management, L.P. 36,786$3,167,0003.70%
Dundas Partners LLP 196,133$16,887,0003.69%
View complete list of BAXTER INTL INC shareholders